MEOH vs. CC, CNQ, CVE, DVN, HAL, LYB, MUR, OVV, SM, and SU
Should you be buying Methanex stock or one of its competitors? The main competitors of Methanex include Chemours (CC), Canadian Natural Resources (CNQ), Cenovus Energy (CVE), Devon Energy (DVN), Halliburton (HAL), LyondellBasell Industries (LYB), Murphy Oil (MUR), Ovintiv (OVV), SM Energy (SM), and Suncor Energy (SU).
Methanex vs. Its Competitors
Chemours (NYSE:CC) and Methanex (NASDAQ:MEOH) are both mid-cap basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, media sentiment, analyst recommendations and risk.
76.3% of Chemours shares are owned by institutional investors. Comparatively, 73.5% of Methanex shares are owned by institutional investors. 0.5% of Chemours shares are owned by company insiders. Comparatively, 1.0% of Methanex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Chemours presently has a consensus price target of $17.38, suggesting a potential upside of 15.14%. Methanex has a consensus price target of $44.88, suggesting a potential upside of 20.99%. Given Methanex's stronger consensus rating and higher probable upside, analysts plainly believe Methanex is more favorable than Chemours.
Methanex has a net margin of 7.02% compared to Chemours' net margin of -7.19%. Chemours' return on equity of 35.14% beat Methanex's return on equity.
In the previous week, Chemours had 5 more articles in the media than Methanex. MarketBeat recorded 13 mentions for Chemours and 8 mentions for Methanex. Methanex's average media sentiment score of 1.26 beat Chemours' score of 1.02 indicating that Methanex is being referred to more favorably in the news media.
Methanex has lower revenue, but higher earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Methanex, indicating that it is currently the more affordable of the two stocks.
Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.3%. Methanex pays an annual dividend of $0.74 per share and has a dividend yield of 2.0%. Chemours pays out -12.5% of its earnings in the form of a dividend. Methanex pays out 21.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Methanex has raised its dividend for 4 consecutive years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.
Chemours has a beta of 1.61, indicating that its stock price is 61% more volatile than the S&P 500. Comparatively, Methanex has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500.
Summary
Methanex beats Chemours on 12 of the 19 factors compared between the two stocks.
Get Methanex News Delivered to You Automatically
Sign up to receive the latest news and ratings for MEOH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MEOH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Methanex Competitors List
Related Companies and Tools
This page (NASDAQ:MEOH) was last updated on 9/4/2025 by MarketBeat.com Staff